Header Logo

Connection

ANITA DESWAL to Stroke Volume

Back to Details
This is a "connection" page, showing publications ANITA DESWAL has written about Stroke Volume.
ANITA DESWAL
Connection Strength
5.191
Stroke Volume
  1. Obesity and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021 Jul; 17(3):345-356.
    View in: PubMed
    Score: 0.566
  2. Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2018 Oct; 14(4):525-535.
    View in: PubMed
    Score: 0.464
  3. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.417
  4. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2014 Aug; 20(8):560-8.
    View in: PubMed
    Score: 0.346
  5. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.341
  6. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.297
  7. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.281
  8. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol. 2008 May; 23(3):233-40.
    View in: PubMed
    Score: 0.227
  9. Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. ESC Heart Fail. 2026 May 05; 13(3).
    View in: PubMed
    Score: 0.198
  10. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006 Apr 15; 97(8):1228-31.
    View in: PubMed
    Score: 0.195
  11. Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025 Nov; 27(11):2152-2167.
    View in: PubMed
    Score: 0.189
  12. THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARD. Trans Am Clin Climatol Assoc. 2025; 135:43-51.
    View in: PubMed
    Score: 0.180
  13. GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2025 07; 31(7):989-1001.
    View in: PubMed
    Score: 0.180
  14. In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk. Ann Intern Med. 2023 12; 176(12):JC136.
    View in: PubMed
    Score: 0.167
  15. Catheter Ablation of Atrial Fibrillation in?Persons With HFpEF: We Can All Breathe Easier Now! JACC Heart Fail. 2023 06; 11(6):659-661.
    View in: PubMed
    Score: 0.160
  16. Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study. J Am Heart Assoc. 2020 10 20; 9(19):e014669.
    View in: PubMed
    Score: 0.134
  17. Heart?Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint. J Am Coll Cardiol. 2019 12 10; 74(23):2905-2907.
    View in: PubMed
    Score: 0.127
  18. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail. 2016 08; 9(8).
    View in: PubMed
    Score: 0.101
  19. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
    View in: PubMed
    Score: 0.097
  20. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014 Jan; 7(1):123-30.
    View in: PubMed
    Score: 0.083
  21. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J. 2012 Nov; 164(5):763-770.e3.
    View in: PubMed
    Score: 0.077
  22. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.064
  23. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006 Aug; 152(2):348-54.
    View in: PubMed
    Score: 0.050
  24. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease. J Card Fail. 2005 Apr; 11(3):206-12.
    View in: PubMed
    Score: 0.046
  25. Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol. 2004 Oct 15; 94(8):1003-7.
    View in: PubMed
    Score: 0.044
  26. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.031
  27. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
    View in: PubMed
    Score: 0.030
  28. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail. 2015 Nov; 8(6):1052-8.
    View in: PubMed
    Score: 0.024
  29. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.
    View in: PubMed
    Score: 0.023
  30. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013 Mar 27; 309(12):1268-77.
    View in: PubMed
    Score: 0.020
  31. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.017
  32. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.